Skip to content

US · NOVT · HARDWARE, EQUIPMENT & PARTS

Novanta Inc. (NOVT) intrinsic value and stock valuation

$101.99as of 2026-11-21 · Mkt cap 5.45B

Data updated · price as of 2026-11-21

OvervaluedIC value is 20–50% below the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Novanta Inc. DCF and intrinsic value

InvestorsCraft values NOVT with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from NOVT’s statements →

Novanta Inc. Graham Number

Graham Number: $34.48d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Technology · Hardware, Equipment & Parts Bedford, MA 01730 novanta.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$980.6M+10.7% 5y CAGRd
20112025
Net income
$53.8M+3.9% 5y CAGRd
20112025
Free cash flow
$48.4M-17.9% 5y CAGRd
20112025
Total equity
$1.31B+22.5% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$980.6M$949.3M$881.7M$860.9M$706.8M
Operating income$116.7M$110.6M$110.5M$103.1M$64.1M
Net income$53.8M$64.1M$72.9M$74.1M$50.3M
EPSd$1.47M$1.77M$2.02M$2.06M$1.41M
Operating cash flow$64.1M$158.5M$120.1M$90.8M$94.6M
Capital expenditure-$-15.63M-$-17.16M-$-19.96M-$-19.64M-$-22.18M
Free cash flow$48.4M$141.4M$100.1M$71.1M$72.5M
Total assets$1.81B$1.39B$1.23B$1.24B$1.23B
Total debt$341.6M$471M$404.6M$489.4M$493.4M
Net debt-$-39.26M$357M$299.5M$389.3M$376M
Total equity$1.31B$745.7M$673.5M$577.6M$521.3M
Cash and short-term investments$380.9M$114M$105.1M$100.1M$117.4M
Income statement
20252024202320222021
Revenue$980.6M$949.3M$881.7M$860.9M$706.8M
Cost of revenue$572.8M$527.7M$481.8M$482.4M$406.5M
Gross profit$407.8M$421.6M$399.9M$378.5M$300.3M
Research and development expenses$95.5M$95.5M$91.7M$85.8M$72.5M
Selling, general and administrative expenses$195.7M$175.9M$164.5M$158.9M$129.2M
Other expenses$0.00$39.5M$33.3M$30.7M$34.6M
Operating expenses$291.1M$311M$289.4M$275.4M$236.3M
Cost and expenses$863.9M$838.7M$771.2M$757.8M$642.7M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$21.5M$31.5M$25.8M$15.6M$7.39M
Depreciation and amortization$61.9M$55.6M$46.6M$53.2M$43.4M
Ebitda$153.1M$179.9M$169.9M$160.6M$125.5M
Operating income$116.7M$110.6M$110.5M$103.1M$64.1M
Total other income/expenses, net-$-47.02M-$-31.52M-$-26.75M-$-15.92M-$-7.88M
Income before tax$69.6M$79.1M$83.8M$87.2M$56.2M
Income tax expense$15.8M$15M$10.9M$13.1M$5.84M
Net income$53.8M$64.1M$72.9M$74.1M$50.3M
Weighted average shares outstanding$36.6M$36M$35.8M$35.7M$35.4M
Weighted average diluted shares outstanding$36.7M$36.1M$36M$35.9M$35.8M
Balance sheet
20252024202320222021
Cash and short-term investments$380.9M$114M$105.1M$100.1M$117.4M
Net receivables$184.9M$151M$139.4M$137.7M$115.6M
Inventory$188.3M$144.6M$149.4M$168M$125.7M
Total current assets$782.6M$433.7M$415.3M$420.5M$373.8M
Property, plant and equipment, net$160.2M$156M$147.8M$146.5M$135.8M
Goodwill and intangible assets$828.1M$769.9M$629.5M$654.7M$700.5M
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$1.02B$954.9M$810.8M$820.7M$854.1M
Total assets$1.81B$1.39B$1.23B$1.24B$1.23B
Accounts payable$94.9M$76.9M$57.2M$75.2M$68.5M
Short-term debt$49M$15.3M$13.9M$13.3M$13M
Deferred revenue$0.00$5.71M$5.55M$8.13M$7M
Total current liabilities$212.4M$167.8M$139.2M$164.5M$183.9M
Long-term debt$292.6M$455.7M$390.7M$476.1M$480.4M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$280.5M$475M$413.4M$499.1M$522.7M
Capital lease obligations$41.2M$43.7M$41.3M$45.5M$51M
Total liabilities$492.8M$642.8M$552.6M$663.6M$706.6M
Common stock$423.9M$423.9M$423.9M$423.9M$423.9M
Retained earnings$321.4M$267.6M$203.5M$130.6M$56.5M
Accumulated other comprehensive income (loss)-$-3M-$-29.92M-$-24.04M-$-32.01M-$-12.87M
Total equity$1.31B$745.7M$673.5M$577.6M$521.3M
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$341.6M$471M$404.6M$489.4M$493.4M
Net debt-$-39.26M$357M$299.5M$389.3M$376M
Cash flow statement
20252024202320222021
Net income$53.8M$64.1M$72.9M$74.1M$50.3M
Depreciation and amortization$61.9M$55.6M$46.6M$53.2M$43.4M
Stock-based compensation$29.5M$23.3M$25.6M$23.1M$25.6M
Change in working capital-$-75.13M$18.9M-$-21.33M-$-44.74M-$-27.01M
Accounts receivable-$-27.27M-$-6.19M-$-130K-$-23.25M-$-25.36M
Inventory-$-36.1M$4.78M$11.4M-$-48.55M-$-19.08M
Accounts payable$3.71M$13.1M-$-20.45M$30.3M$24.5M
Net cash provided by operating activities$64.1M$158.5M$120.1M$90.8M$94.6M
Investments in property, plant and equipment-$-15.63M-$-17.16M-$-19.96M-$-19.64M-$-22.18M
Acquisitions, net-$-64.29M-$-191.2M$0.00-$-21.57M-$-284.73M
Net cash used for investing activities-$-74.32M-$-208.19M-$-19.89M-$-42.54M-$-306.7M
Common stock issued$614.4M$0.00$0.00$0.00$0.00
Common stock repurchased-$-39.28M$0.00-$-10.56M-$-10M$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$276.3M$56.9M-$-97.85M-$-60.15M$204.8M
Net change in cash$266.9M$8.94M$4.95M-$-17.29M-$-7.66M
Cash at end of period$380.9M$114M$105.1M$100.1M$117.4M
Operating cash flow$64.1M$158.5M$120.1M$90.8M$94.6M
Capital expenditure-$-15.63M-$-17.16M-$-19.96M-$-19.64M-$-22.18M
Free cash flow$48.4M$141.4M$100.1M$71.1M$72.5M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Novanta Inc.

        Operating globally, Novanta Inc. and its affiliated companies specialize in the development, production, and distribution of advanced photonics, vision, and precision motion components and sub-assemblies. These highly engineered solutions are supplied to Original Equipment Manufacturers (OEMs) across the medical and industrial sectors. Within its Photonics division, Novanta provides a suite of laser-driven technologies. These encompass systems for laser scanning, beam manipulation, and various laser types such as CO2, solid-state, ultrafast, and optical light engines. Their applications span critical areas like industrial manufacturing, precision measurement (metrology), advanced imaging in healthcare and biological research, DNA sequencing, and specialized medical laser treatments. The Vision segment delivers an array of medical-grade innovations. This portfolio comprises instruments like medical insufflators, pumps, and their associated consumables, alongside comprehensive visualization tools. It also features wireless communication systems, video recording devices, and integration platforms designed for operating theaters. Further offerings include optical data acquisition, machine vision systems, radio frequency identification (RFID) solutions, thermal recording devices, spectrometry equipment, and integrated touchscreen displays. Furthermore, the Precision Motion division specializes in supplying components such as optical and inductive encoders, high-precision motors, servo drives, and complete motion control systems. This segment also delivers integrated stepper motors, sophisticated robotic end-effectors, air bearings, and air bearing spindles. Novanta distributes its extensive product lines through various channels, including its dedicated direct sales team, value-added resellers, distribution partners, and system integrators. These offerings are available under well-known brand names such as Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind. Founded in 1968, the company operated as GSI Group, Inc. until its rebranding to Novanta Inc. in May 2016. Its corporate headquarters are located in Bedford, Massachusetts.

        CEO
        Matthijs Glastra
        Employees
        3K
        Beta
        1.68

        Explore

        Frequently asked questions

        What is the intrinsic value of Novanta Inc. (NOVT)?

        Novanta Inc. (NOVT) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is NOVT undervalued?

        NOVT trades at a price of $101.99 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.